Study about reduction of vulvar Pain

New website features promising clinical study results for women suffering from painful disease

(NEW YORK, NY) July 2011 – This summer, a new website offers a place for doctors and patients to view a clinical study which demonstrates promising results for a chronic pain syndrome affecting approximately 14 million American women. features the clinical study investigated by Dr. Gilbert G. Donders, which evaluates the efficacy and safety of NeoGyn® Vulvar Soothing Cream in women suffering from Vulvodynia. The disease’s main symptom, chronic vulvar pain without an identifiable cause, has a significant impact on a woman’s quality of life.

The study consisted of 30 patients suffering from vulvar pain. The patients were tested over a three-month period. The results show that during the first 12 weeks, use of NeoGyn® Vulvar Soothing Cream resulted in significant reduction of pain during sexual activity.

Key findings include the subjects reporting an improvement of more than 20% in comfort during sexual activity at the end of 12 weeks and excellent tolerability with the use of NeoGyn® rather than the placebo which did not provide any significant relief. The results of subjects pain reduction and redness reduction from the study can be found in the charts below.

Dr. Gilbert G. Donders, a Professor of Obstetrics and Gynecology at the University of Leuven in Belgium, is the investigator behind the study. After learning about the new vulvar soothing cream under development (NeoGyn® Vulvar Soothing Cream) Dr. Donders was driven by his commitment to the gynecological needs of women and was able to obtain approval for the first placebo-controlled study with the cream, completing the study in 2010.

For more information and to view the study and results, please visit

PR Contacts:
Kira Kohrherr
K Public Relations LLC
[email protected]

Nicole Schade
K Public Relations LLC
[email protected]

No Comments Found

Leave a Reply